Walleye Capital’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,643
Closed -$164K 3960
2022
Q3
$164K Hold
16,643
﹤0.01% 2219
2022
Q2
$164K Hold
16,643
﹤0.01% 1593
2022
Q1
$165K Buy
16,643
+4,980
+43% +$49.4K ﹤0.01% 1599
2021
Q4
$117K Sell
11,663
-80,216
-87% -$803K ﹤0.01% 1633
2021
Q3
$915 Hold
91,879
0.03% 488
2021
Q2
$925 Buy
91,879
+1,879
+2% +$18.8K 0.03% 478
2021
Q1
$897 Buy
+90,000
New +$916K 0.05% 340

Walleye Capital's SHACU Position: Q4 2022 in Review

Walleye Capital sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q4 2022, closing a stake of 16,643 shares — an estimated $164K sold.

Walleye Capital first reported a position in SHACU in Q1 2021 and held it in 7 quarters. The position peaked at $165K in Q1 2022. 0 funds tracked by Wall St. Rank hold SHACU as of Q4 2022.

  • Walleye Capital reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 16,643 SCP & CO Healthcare Acquisition Company Unit shares in Q4 2022, an estimated $164K.
  • Walleye Capital first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 7 quarters.
  • Walleye Capital's SCP & CO Healthcare Acquisition Company Unit position peaked at $165K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.